Search
Efmoroctocog alfa
go.drugbank.com/drugs/DB11607ApprovedInvestigationalFactor VIII is a blood coagulant factor involved in the intrinsic pathway to form fibrin, or a blood clot. … It is an antihemorrhagic agent used in replacement therapy for patients with haemophilia A (congenital factor VIII deficiency). It is suitable for all age groups.
Products: ELOCTATE® 250 UI, ELOCTATE® 500 UIIsavuconazole
go.drugbank.com/drugs/DB11633ApprovedInvestigationalResistance to isavuconazole has been associated with the mutation in the target gene CYP51 [FDA Label]. … Following administration, isavuconazonium undergoes biotransformation to form the active moiety, isavuconazole, for the antifungal actions.
Categories: Antimycotics for Systemic Use, Antiinfectives for Systemic UseProducts: CRESEMBA (POWDER FOR SOLUTION FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200 MG/VIAL)Streptomycin
go.drugbank.com/drugs/DB01082ApprovedInvestigationalVet approved[A233325,A233390] Selman Waksman and eventually Albert Schatz were recognized with the Nobel Prize in Medicine for their discovery of streptomycin and its antibacterial activity. … Streptomycin, an antibiotic derived from _Streptomyces griseus_, was the first aminoglycoside to be discovered and used in practice in the 1940s.
Synonyms: 2,4-diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranosideCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseAminocaproic acid
go.drugbank.com/drugs/DB00513ApprovedInvestigationalAn antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
Mixtures: Gray Salt, Salt ToothInternational brands: Kai Nai YinIsavuconazonium
go.drugbank.com/drugs/DB06636ApprovedInvestigational[A6913,A6914,A262706] On December 08, 2023, the FDA approved the expanded use of isovuconazonium in pediatric patients for the same indications.[L49251] … Due to low solubility in water of isavuconazole on its own, the isovuconazonium formulation is favorable as it has high solubility in water and allows for intravenous administration.
Products: CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MGCarboxymethylcellulose
go.drugbank.com/drugs/DB11059ApprovedInvestigationalIt is added in food products as a viscosity modifier or thickener and emulsifier. … The viscous and mucoadhesive properties as well as its anionic charge allow prolonged retention time in the ocular surface [A33029]. Sodium carboxymethylcellulose is the most commonly used salt.
Mixtures: Clear Eyes for Dry Eyes, GenTeal Moderate to SevereCategories: Compounds used in a research, industrial, or household settingEpendymoma
go.drugbank.com/conditions/DBCOND0017183Drugs: CarmustineSynonyms: Ependymoma, no International Classification of Diseases for Oncology subtype, Ependymoma, no ICD-O subtypeChronic Myeloid Leukemia in Myeloid Blast Crisis
go.drugbank.com/conditions/DBCOND0059451Drugs: VindesineSynonyms: Blast crisis in myelogenous leukaemia, Blast crisis in myelogenous leukemiaRefractory Anemia With Excess Blasts in Transformation
go.drugbank.com/conditions/DBCOND0028567Drugs: AzacitidineSynonyms: Refractory Anemia With Excess of Blasts in Transformation, Refractory Anemia With Excess Blasts in TransformationInfection in minor cuts, scrapes, or burns
go.drugbank.com/conditions/DBCOND0021991Synonyms: Infection in minor cuts, scrapes, or burns